NCT06570967 A Clinical Study of Hyperthyroidism in Children
| NCT ID | NCT06570967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shengjing Hospital |
| Condition | Hyperthyroidism |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-07-18 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-07-18 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.
Eligibility Criteria
Inclusion Criteria: 1. Age ≤14 years old 2. Initial diagnosis of hyperthyroidism Exclusion Criteria: 1. Hyperthyroidism had been treated with medication in other hospitals, 2. History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation, 3. Patients with incomplete clinical data
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06570967 clinical trial?
This trial is open to participants of all sexes, aged 29 Days or older, up to 14 Years, studying Hyperthyroidism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06570967 currently recruiting?
Yes, NCT06570967 is actively recruiting participants. Contact the research team at ts047827@163.com for enrollment information.
Where is the NCT06570967 trial being conducted?
This trial is being conducted at Shenyang, China.
Who is sponsoring the NCT06570967 clinical trial?
NCT06570967 is sponsored by Shengjing Hospital. The trial plans to enroll 1,000 participants.